Medrio Overview

  • Founded
  • 2005
Founded
  • Status
  • Private
  • Employees
  • 185
Employees
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 9

Medrio General Information

Description

Provider of clinical software products designed for clinical studies in all phases and therapeutic areas. The company's software platform and a mobile suite of products provide web-based electronic data for clinical research applications and also support various processes for clinical research, study design, data collection, management reports, statistical analyses and presentation, enabling study sponsors and contract research organizations (CROs) to rapidly set-up and conduct clinical trials.

Contact Information

Website
www.medrio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Business/Productivity Software
Database Software
Primary Office
  • 345 California Street
  • Suite 325
  • San Francisco, CA 94104
  • United States
+1 (415) 000-0000

Medrio Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Medrio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 04-Sep-2020 000.00 Completed Generating Revenue
4. Debt - PPP 27-Apr-2020 00.000 000.00 Completed Generating Revenue
3. Later Stage VC 24-May-2017 0000 000.00 00000 Completed Generating Revenue
2. Later Stage VC 01-Jun-2013 $1.6M $3.63M 000.00 Completed Generating Revenue
1. Seed Round 28-Oct-2011 $2.03M $2.03M 0000 Completed Generating Revenue
To view Medrio’s complete valuation and funding history, request access »

Medrio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series Growth 0,000,000 00.000000 00.0 00.00 00.00 00 00.00 000
Series 1 000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Seed 4,428,068 $0.000100 $0.09 $1.2 $1.2 1x $1.2 22.46%
To view Medrio’s complete cap table history, request access »

Medrio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of clinical software products designed for clinical studies in all phases and therapeutic areas. The company's
Enterprise Systems (Healthcare)
San Francisco, CA
185 As of 2021
000.00
00000000000 000.00

00000000

exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repr
0000000000 0000000 (0000000000)
Montreal, Canada
000000000

00000000

dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut ali
0000000000000 00000000
Mansfield, MA
000 As of 0000
000.00
0000000 0000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Medrio Competitors (36)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Montrium Private Debt Financed Montreal, Canada 000000000
000000000 00000000 Private Equity-Backed Mansfield, MA 000 000.00 0000000 0000 000.00
000000 (0000000 00 Venture Capital-Backed Amsterdam, Netherlands 000 000.00 00000000000 000.00
00000000 000 Private Equity-Backed Horsham, PA 000 000.00 0000000 0000
000000 Private Equity-Backed Uppsala, Sweden 00 000000000000
You’re viewing 5 of 36 competitors. Get the full list »

Medrio Executive Team (12)

Name Title Board Seat Contact Info
Nicole Latimer Chief Executive Officer & Board Member
Edward Gould Chief Financial Officer
Christina Hughes Chief Operating Officer
Fred Martin Chief Product Officer
Mike Novotny Founder & Board Member
You’re viewing 5 of 12 executive team members. Get the full list »

Medrio Board Members (7)

Name Representing Role Since
Bradley Sloan Questa Capital Board Member 000 0000
Dave Lipscomb Self Board Member 000 0000
Doug Engfer Medrio Board Member 000 0000
Emily Conley Ph.D Self Board Member 000 0000
Mike Novotny Medrio Founder & Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Medrio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Medrio Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Questa Capital Venture Capital Minority 000 0000 000000 0
Think + Venture Capital Minority 000 0000 000000 0
Montage Capital Mezzanine Minority 000 0000 000000 0
Thanos Triant Angel (individual) Minority 000 0000 000000 0
Bill Tobin Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Medrio Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 00000000 15-Apr-2021 0000000000 IT Consulting and Outsourcing 000000 00
DFS Pharma Merger/Acquisition Systems and Information Management 000000 00
To view Medrio’s complete acquisitions history, request access »